(MENAFN-IANOS)
Stockholm, Nov 3 (IANS) Nuvaxovid, the Covid-19 vaccine created by the US company Novavax, will not be given to other people under the age of 30, the Swedish Public Health Agency said in Stockholm, the Swedish capital.
The company on Wednesday cited a study conducted in Australia, which showed an increased risk of myocarditis (inflammation of the central muscle) and pericarditis (inflammation of the tissues surrounding the center) after vaccination, Xinhua news company reported.
“We are tracking a lot and waiting for more data,” Soren Andersson, head of the agency’s immunization programs unit, said in a statement.
About 7,000 doses of Nuvaxovid have already been administered in Sweden. The firm said young people who had recently been vaccinated with Nuvaxovid had no explanation for why to worry because “the threat is very low” and they may continue with the next dose of vaccine type.
People over 30 can still get vaccinated with Nuvaxovid and the firm said the resolution on the use of the vaccine is temporary, pending further investigation.
–IANOS
integer/khz/
HOMBREFN02112022000231011071ID1105122581
Key words
Feedback
Category
Date